{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:20Z","timestamp":1790700560760,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2524,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1469-0691.2007.01849.x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T12:29:04Z","timestamp":1202473744000},"page":"53-62","source":"Crossref","is-referenced-by-count":102,"special_numbering":"S1","title":["IRT and CMT \u03b2-lactamases and inhibitor resistance"],"prefix":"10.1016","volume":"14","author":[{"given":"R.","family":"Cant\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Morosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Gomez G.","family":"de la Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2007.01849.x_bib1","first-page":"895","article-title":"The reactivity of \u03b2-lactams, the mechanism of catalysis and the inhibition of \u03b2-lactamases","volume":"5","author":"Page","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/CMR.1.1.109","article-title":"\u03b2-Lactamase inhibitors from laboratory to clinic","volume":"1","author":"Bush","year":"1988","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding the longevity of the \u03b2-lactam antibiotics and of antibiotic\/\u03b2-lactamase inhibitor combinations","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/AAC.33.8.1131","article-title":"Extended-spectrum \u03b2-lactamases","volume":"33","author":"Philippon","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M \u03b2-lactamase pandemic","volume":"9","author":"Cant\u00f3n","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib6","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/AAC.39.12.2593","article-title":"Extended-spectrum and inhibitor-resistant TEM-type \u03b2-lactamases: mutations, specificity, and three-dimensional structure","volume":"39","author":"Knox","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/40.1.1","article-title":"Inhibitor-resistant \u03b2-lactamases","volume":"40","author":"Nicolas-Chanoine","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib8","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2741\/Bonomo","article-title":"Inhibitor resistant class A \u03b2-lactamases","volume":"4","author":"Bonomo","year":"1999","journal-title":"Front Biosci"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jac\/43.4.447","article-title":"Inhibitor-resistant TEM \u03b2-lactamases: phenotypic, genetic and biochemical characteristics","volume":"43","author":"Chaibi","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib10","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/AAC.37.10.2059","article-title":"Characterization of a new TEM-type \u03b2-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli","volume":"37","author":"Bl\u00e1zquez","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/34.5.707","article-title":"Frequency of inhibitor-resistant TEM \u03b2-lactamases in Escherichia coli isolates from urinary tract infections in France","volume":"34","author":"Henquell","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/49.2.367","article-title":"Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection","volume":"49","author":"Leflon-Guibout","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.32.9.1365","article-title":"Resistance to ticarcillin\u2013potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 \u03b2-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests","volume":"32","author":"Sanders","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jac\/40.4.533","article-title":"Bases of variation in resistance to \u03b2-lactams in Klebsiella oxytoca isolates hyperproducing K1 beta-lactamase","volume":"40","author":"Gheorghiu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jac\/dki149","article-title":"Hyperproduction of AmpC \u03b2-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampC","volume":"56","author":"Fern\u00e1ndez-Cuenca","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib17","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1099\/00221287-137-12-2681","article-title":"An IS1-like element is responsible for high-level synthesis of extended-spectrum \u03b2-lactamase TEM-6 in Enterobacteriaceae","volume":"137","author":"Goussard","year":"1991","journal-title":"J Gen Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/36.6.927","article-title":"Mechanisms of hyperproduction of TEM-1 \u03b2-lactamase by clinical isolates of Escherichia coli","volume":"36","author":"Wu","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib19","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/AAC.39.11.2478","article-title":"Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli","volume":"39","author":"Stapleton","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/40.4.525","article-title":"Mechanism and stability of hyperproduction of the extended-spectrum \u03b2-lactamase SHV-5 in Klebsiella pneumoniae","volume":"40","author":"Xiang","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib21","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.46.12.4035-4037.2002","article-title":"Promoters P3, Pa\/Pb, P4, and P5 upstream from blaTEM genes and their relationship to \u03b2-lactam resistance","volume":"46","author":"Lartigue","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0140-6736(87)91180-9","article-title":"Resistance to \u03b2-lactam\/clavulanate","volume":"2","author":"Martinez","year":"1987","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/42.4.535","article-title":"Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction","volume":"42","author":"Miro","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/27.5.569","article-title":"Factors determining resistance to \u03b2-lactam combined with \u03b2-lactamase inhibitors in Escherichia coli","volume":"27","author":"Reguera","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib25","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.48.10.3758-3764.2004","article-title":"Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum \u03b2-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada","volume":"48","author":"Boyd","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.38.5.1085","article-title":"Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 \u03b2-lactamase conferring resistance to \u03b2-lactamase inhibitors","volume":"38","author":"Zhou","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib27","first-page":"865","article-title":"OXA-type \u03b2-lactamases","volume":"5","author":"Naas","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jac\/37.1.190","article-title":"Problems encountered in the characterization of IRT \u03b2-lactamase-producing clinical Escherichia coli isolates intermediateresistant to cephalothin","volume":"37","author":"Cha\u00efbi","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib29","first-page":"113","article-title":"TRC-1: emergence of a clavulanic acid-resistant TEM \u03b2-lactamase in a clinical strain","volume":"43","author":"Thompson","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib30","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.45.7.2179-2180.2001","article-title":"Inhibitor resistant TEM-33 \u03b2-lactamase in a Shigella sonnei isolate","volume":"45","author":"Sirot","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/30.4.449","article-title":"Clinical isolates of Escherichia coli producing TRI \u03b2-lactamases: novel TEM-enzymes conferring resistance to \u03b2-lactamase inhibitors","volume":"30","author":"Vedel","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib32","doi-asserted-by":"crossref","first-page":"32149","DOI":"10.1074\/jbc.M204212200","article-title":"The structural bases of antibiotic resistance in the clinically derived mutant \u03b2-lactamases TEM-30, TEM-32, and TEM-34","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib33","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1021\/bi0502700","article-title":"Structural consequences of the inhibitor-resistant Ser130Gly substitution in TEM \u03b2-lactamase","volume":"44","author":"Thomas","year":"2005","journal-title":"Biochemistry"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/AAC.39.2.427","article-title":"Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM \u03b2-lactamases from clinical isolates of Escherichia coli","volume":"39","author":"Henquell","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/PL00006121","article-title":"Molecular diversity and evolution of blaTEM genes encoding \u03b2-lactamases resistant to clavulanic acid in clinical E. coli","volume":"44","author":"Canica","year":"1997","journal-title":"J Mol Evol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.38.4.767","article-title":"Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important \u03b2-lactamases","volume":"38","author":"Payne","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-1097(97)00013-X","article-title":"Tazobactam is a potent inactivator of selected inhibitor-resistant class A \u03b2-lactamases","volume":"148","author":"Bonomo","year":"1997","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib38","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.48.5.1520-1525.2004","article-title":"Variety of \u03b2-lactamases produced by amoxicillin\u2013clavulanate-resistant Escherichia coli isolated in the Northeastern United States","volume":"48","author":"Kaye","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib39","first-page":"113","article-title":"\u03b2-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre","volume":"25","author":"Wong","year":"2003","journal-title":"Malays J Pathol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib40","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.46.12.3991-3994.2002","article-title":"Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant \u03b2-lactamases at a university hospital in Barcelona, Spain, over a 3-year period","volume":"46","author":"Mir\u00f3","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1198-743X.2004.00766.x","article-title":"Mechanisms of reduced susceptibility to amoxycillin\u2013clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain)","volume":"10","author":"P\u00e9rez-Moreno","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib42","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/AAC.44.10.2709-2714.2000","article-title":"Epidemiological survey of amoxicillin\u2013clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of blaTEM genes","volume":"44","author":"Leflon-Guibout","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 \u03b2-lactamases in New York City","volume":"39","author":"Bradford","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jac\/45.4.467","article-title":"Molecular epidemiology of an outbreak due to IRT-2 \u03b2-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department","volume":"45","author":"Girlich","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib45","first-page":"34","article-title":"D\u00e9tection en routine des \u03b2-lactamases TEM r\u00e9sistentes aux inhibiteurs (IRT) et des oxacillinases (OXA) chez Escherichia coli","volume":"45","author":"Libert","year":"1997","journal-title":"Pathol Biol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib46","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/AAC.43.4.862","article-title":"Ampicillin\u2013sulbactam and amoxicillin\u2013clavulanate susceptibility testing of Escherichia coli isolates with different \u03b2-lactam resistance phenotypes","volume":"43","author":"Oliver","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib47","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/AAC.39.11.2591","article-title":"Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio","volume":"39","author":"Thomson","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/BF01691379","article-title":"Activity of \u03b2-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to \u03b2-lactam agents","volume":"14","author":"Vanjak","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0034-5288(93)90109-S","article-title":"Plasmid encoded \u03b2-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms","volume":"55","author":"Hunter","year":"1993","journal-title":"Res Vet Sci"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib50","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/AAC.46.5.1183-1189.2002","article-title":"TEM-80, a novel inhibitor-resistant \u03b2-lactamase in a clinical isolate of Enterobacter cloacae","volume":"46","author":"Arpin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib51","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.39.11.2580","article-title":"First characterization of inhibitor-resistant TEM (IRT) \u03b2-lactamases in Klebsiella pneumoniae strains","volume":"39","author":"Lemozy","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/AAC.46.4.1158-1159.2002","article-title":"First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate","volume":"46","author":"Granier","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib53","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/JCM.44.5.1630-1634.2006","article-title":"Longitudinal farm study of extended-spectrum \u03b2-lactamase-mediated resistance","volume":"44","author":"Liebana","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib54","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/AAC.41.6.1322","article-title":"A complex mutant of TEM-1 \u03b2-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate","volume":"41","author":"Sirot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib55","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/AAC.44.6.1499-1505.2000","article-title":"A novel complex mutant \u03b2-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum \u03b2-lactamase-producing klebsiellae","volume":"44","author":"Fiett","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib56","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.45.12.3591-3594.2001","article-title":"TEM-89 \u03b2-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3","volume":"45","author":"Neuwirth","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib57","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.48.12.4528-4531.2004","article-title":"TEM-121, a novel complex mutant of TEM-type \u03b2-lactamase from Enterobacter aerogenes","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib58","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1128\/AAC.49.11.4443-4447.2005","article-title":"TEM-109 (CMT-5), a natural complex mutant of TEM-1 \u03b2-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5)","volume":"49","author":"Robin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib59","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/AAC.01639-05","article-title":"CMT-type \u03b2-lactamase TEM-125, an emerging problem for extended-spectrum \u03b2-lactamase detection","volume":"50","author":"Robin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib60","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01058-06","article-title":"Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient","volume":"51","author":"Robin","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib61","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/bies.950190814","article-title":"Selective compartments for resistant microorganisms in antibiotic gradients","volume":"19","author":"Baquero","year":"1997","journal-title":"Bioessays"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib62","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1128\/AAC.47.8.2551-2557.2003","article-title":"Haemophilus influenzae blaROB-1 mutations in hypermutagenic \u0394ampC Escherichia coli conferring resistance to cefotaxime and \u03b2-lactamase inhibitors and increased susceptibility to cefaclor","volume":"47","author":"Gal\u00e1n","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib63","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/47.5.547","article-title":"Amino acid substitutions causing inhibitor resistance in TEM \u03b2-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum \u03b2-lactamases","volume":"47","author":"Randegger","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib64","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/AAC.43.8.1881","article-title":"Construction and characterization of mutants of the TEM-1 \u03b2-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to \u03b2-lactamase inhibitors","volume":"43","author":"Stapleton","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib65","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1128\/AAC.48.11.4466-4469.2004","article-title":"SHV-49, a novel inhibitor-resistant \u03b2-lactamase in a clinical isolate of Klebsiella pneumoniae","volume":"48","author":"Dubois","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.41.4.838","article-title":"Emergence of an inhibitor-resistant \u03b2-lactamase (SHV-10) derived from an SHV-5 variant","volume":"41","author":"Prinarakis","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01849.x_bib67","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/AAC.00473-06","article-title":"Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6\u2019)-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme","volume":"50","author":"Machado","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:46:27Z","timestamp":1557258387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14604754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":67,"alternative-id":["S1198743X14604754"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01849.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}